Pharmicell Co., Ltd. (KRX:005690)

Pharmicell Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jan 8, 2026	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Market Capitalization	828,055	164,023	213,530	370,682	173,375	75,442
Market Cap Growth	129.62%	-23.18%	-42.39%	113.80%	129.81%	169.18%
Enterprise Value	-	172,343	219,632	376,638	176,424	72,037
Last Close Price	13800.00	3770.55	5087.25	10495.95	7173.02	3723.00
PS Ratio	34.58	4.91	19.22	36.05	24.02	10.50
PB Ratio	9.83	1.99	2.10	4.48	17.50	5.47
P/TBV Ratio	16.72	3.44	3.27	6.61	17.60	5.52
EV/Sales Ratio	-	5.16	19.77	36.63	24.44	10.02
Debt / Equity Ratio	0.14	0.11	0.27	0.18	1.40	0.63
Asset Turnover	0.21	0.28	0.09	0.16	0.27	0.37
Inventory Turnover	5.05	5.13	2.65	5.22	4.84	4.81
Quick Ratio	1.05	0.68	0.89	0.73	0.70	4.77
Current Ratio	1.34	1.09	1.08	0.91	0.85	5.41
Return on Equity (ROE)	-29.25%	-27.93%	-19.14%	-39.23%	-100.35%	-39.62%
Return on Assets (ROA)	-4.98%	-4.16%	-7.50%	-14.69%	-24.61%	-7.89%
Return on Capital (ROIC)	-5.33%	-4.46%	-7.85%	-15.78%	-28.29%	-8.58%
Return on Capital Employed (ROCE)	-10.50%	-9.10%	-13.50%	-18.20%	-99.10%	-11.90%
Earnings Yield	-3.23%	-15.67%	-8.26%	-4.90%	-6.84%	-5.24%
FCF Yield	-0.94%	-1.93%	-6.72%	-4.54%	-5.16%	-7.77%
Buyback Yield / Dilution	-7.56%	-11.91%	-44.48%	-1161.86%	86.50%	8.16%

Updated Aug 29, 2014. Source: S&P Global Market Intelligence. Standard template. Financial Sources.